Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Abdul Muqtadir Abbasi
Observed name:
A. Abbasi
Institution:
King Faisal Specialist Hospital & Research Centre
Observed institutions:
Aga Khan University,
King Faisal Specialist Hospital & Research Centre,
Aga Khan University Hospital,
The Ohio State University
ORCID:
0000-0002-6221-6355
Observed ORCID:
0000-0002-6221-6355
OpenAlex ID:
A5015175040
Outcome of patients with primary and secondary hemophagocytic lymphohistiocytosis: A retrospective analysis from a tertiary care center
2023
·
Abdul Muqtadir Abbasi
, Mohammad Usman Shaikh
, et al.
·
Medicine
·
8
Response of Eltrombopag in immune thrombocytopenia and acquired idiopathic aplastic anemia: A single-center experience
2022
·
Abdul Muqtadir Abbasi
, Mohammad Usman Shaikh
, et al.
·
Leukemia Research Reports
·
6
PDF
Fludarabine-based salvage therapy for refractory/relapsed acute leukemias: A single center experience
2021
·
Abdul Muqtadir Abbasi
, Usman Shaikh
, et al.
·
Leukemia Research Reports
·
3
PDF
Spontaneous splenic rupture – An uncommon complication of chronic myelomonocytic leukemia
2020
·
Abdul Muqtadir Abbasi
, Salman Adil
, et al.
·
Leukemia Research Reports
·
3
PDF
Chronic myeloid leukemia developing in treated acute promyelocytic leukemia
2021
·
Abdul Muqtadir Abbasi
, Usman Shaikh
·
Hematology Transfusion and Cell Therapy
·
2
PDF
AML-1354: Risk Stratification of Patients Treated for NPM1-Mutated Acute Myeloid Leukemia: A Single-Center Retrospective Study
2026
·
Zein Sheikh
, Dalal Aldhafeeri
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-1354: Risk Stratification of Patients Treated for NPM1-Mutated Acute Myeloid Leukemia: A Single-Center Retrospective Study
2026
·
Zein Sheikh
, Dalal Aldhafeeri
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
The geographical distribution of clonal hematopoiesis-associated mutations among patients diagnosed with myeloid neoplasms
2025
·
Dalal Aldhafeeri
, Abdullah Bukhari
, et al.
·
Blood
A Phase Ii Trial of Brentuximab Vedotin (bv) and Lenalidomide (len) in Relapsed and Refractory (r/r) Cutaneous (ctcl) and Peripheral (ptcl) T‐cell Lymphomas: Preliminary Results of a Phase Ii Trial
2019
·
B.M. William
, A. Abbasi
, et al.
·
Hematological Oncology
Show more works
View as search
Works count:
9
Citation count:
22
H-index:
3
I10-index:
Year
Topic
Type